These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31729751)

  • 1. ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope.
    Textoris-Taube K; Cammann C; Henklein P; Topfstedt E; Ebstein F; Henze S; Liepe J; Zhao F; Schadendorf D; Dahlmann B; Uckert W; Paschen A; Mishto M; Seifert U
    Eur J Immunol; 2020 Feb; 50(2):270-283. PubMed ID: 31729751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition.
    Keller M; Ebstein F; Bürger E; Textoris-Taube K; Gorny X; Urban S; Zhao F; Dannenberg T; Sucker A; Keller C; Saveanu L; Krüger E; Rothkötter HJ; Dahlmann B; Henklein P; Voigt A; Kuckelkorn U; Paschen A; Kloetzel PM; Seifert U
    Eur J Immunol; 2015 Dec; 45(12):3257-68. PubMed ID: 26399368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
    Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
    Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing.
    Textoris-Taube K; Keller C; Liepe J; Henklein P; Sidney J; Sette A; Kloetzel PM; Mishto M
    J Biol Chem; 2015 Dec; 290(51):30417-28. PubMed ID: 26507656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.
    Urban S; Textoris-Taube K; Reimann B; Janek K; Dannenberg T; Ebstein F; Seifert C; Zhao F; Kessler JH; Halenius A; Henklein P; Paschke J; Cadel S; Bernhard H; Ossendorp F; Foulon T; Schadendorf D; Paschen A; Seifert U
    J Immunol; 2012 Jul; 189(2):529-38. PubMed ID: 22706083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in Mice.
    Schmidt K; Keller C; Kühl AA; Textor A; Seifert U; Blankenstein T; Willimsky G; Kloetzel PM
    Cancer Res; 2018 Jun; 78(12):3243-3254. PubMed ID: 29559473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma.
    Kamphausen E; Kellert C; Abbas T; Akkad N; Tenzer S; Pawelec G; Schild H; van Endert P; Seliger B
    Cancer Immunol Immunother; 2010 Aug; 59(8):1273-84. PubMed ID: 20419298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.
    Saveanu L; Carroll O; Lindo V; Del Val M; Lopez D; Lepelletier Y; Greer F; Schomburg L; Fruci D; Niedermann G; van Endert PM
    Nat Immunol; 2005 Jul; 6(7):689-97. PubMed ID: 15908954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation.
    Firat E; Saveanu L; Aichele P; Staeheli P; Huai J; Gaedicke S; Nil A; Besin G; Kanzler B; van Endert P; Niedermann G
    J Immunol; 2007 Feb; 178(4):2241-8. PubMed ID: 17277129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1.
    Georgiadou D; Hearn A; Evnouchidou I; Chroni A; Leondiadis L; York IA; Rock KL; Stratikos E
    J Immunol; 2010 Aug; 185(3):1584-92. PubMed ID: 20592285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.
    Hearn A; York IA; Rock KL
    J Immunol; 2009 Nov; 183(9):5526-36. PubMed ID: 19828632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERAP2 supports TCR recognition of three immunotherapy targeted tumor epitopes.
    Schmidt K; Leisegang M; Kloetzel PM
    Mol Immunol; 2023 Feb; 154():61-68. PubMed ID: 36608422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells.
    Lauvau G; Kakimi K; Niedermann G; Ostankovitch M; Yotnda P; Firat H; Chisari FV; van Endert PM
    J Exp Med; 1999 Nov; 190(9):1227-40. PubMed ID: 10544195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8
    Reeves E; Wood O; Ottensmeier CH; King EV; Thomas GJ; Elliott T; James E
    Cancer Immunol Res; 2019 Jul; 7(7):1202-1213. PubMed ID: 31151965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cells.
    Chapatte L; Servis C; Valmori D; Burlet-Schiltz O; Dayer J; Monsarrat B; Romero P; Lévy F
    J Immunol; 2004 Nov; 173(10):6033-40. PubMed ID: 15528338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes.
    Ebstein F; Textoris-Taube K; Keller C; Golnik R; Vigneron N; Van den Eynde BJ; Schuler-Thurner B; Schadendorf D; Lorenz FK; Uckert W; Urban S; Lehmann A; Albrecht-Koepke N; Janek K; Henklein P; Niewienda A; Kloetzel PM; Mishto M
    Sci Rep; 2016 Apr; 6():24032. PubMed ID: 27049119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties.
    Hutchinson JP; Temponeras I; Kuiper J; Cortes A; Korczynska J; Kitchen S; Stratikos E
    J Biol Chem; 2021; 296():100443. PubMed ID: 33617882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.
    Fruci D; Ferracuti S; Limongi MZ; Cunsolo V; Giorda E; Fraioli R; Sibilio L; Carroll O; Hattori A; van Endert PM; Giacomini P
    J Immunol; 2006 Apr; 176(8):4869-79. PubMed ID: 16585582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses.
    Zervoudi E; Saridakis E; Birtley JR; Seregin SS; Reeves E; Kokkala P; Aldhamen YA; Amalfitano A; Mavridis IM; James E; Georgiadis D; Stratikos E
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19890-5. PubMed ID: 24248368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
    Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
    Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.